167 related articles for article (PubMed ID: 31965746)
1. Safety and efficacy of baroreflex activation therapy for heart failure with reduced ejection fraction: a rapid systematic review.
Schmidt R; Rodrigues CG; Schmidt KH; Irigoyen MCC
ESC Heart Fail; 2020 Feb; 7(1):3-14. PubMed ID: 31965746
[TBL] [Abstract][Full Text] [Related]
2. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
3. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
[TBL] [Abstract][Full Text] [Related]
4. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
[TBL] [Abstract][Full Text] [Related]
5. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
Eur J Heart Fail; 2024 Apr; 26(4):1051-1061. PubMed ID: 38606555
[TBL] [Abstract][Full Text] [Related]
6. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
7. Long-term chronic baroreflex activation: persistent efficacy in patients with heart failure and reduced ejection fraction.
Gronda E; Seravalle G; Trevano FQ; Costantino G; Casini A; Alsheraei A; Lovett EG; Vanoli E; Mancia G; Grassi G
J Hypertens; 2015 Aug; 33(8):1704-8. PubMed ID: 26132760
[TBL] [Abstract][Full Text] [Related]
8. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single-centre experience.
Blanco C; Madej T; Mangner N; Hommel J; Grimm S; Knaut M; Linke A; Winzer EB
ESC Heart Fail; 2023 Dec; 10(6):3373-3384. PubMed ID: 37667319
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of baroreflex activation therapy for heart failure with reduced ejection fraction: systematic review.
Molina-Linde JM; Cordero-Pereda D; Baños-Álvarez E; Rosario-Lozano MP; Blasco-Amaro JA
ESC Heart Fail; 2023 Oct; 10(5):2760-2772. PubMed ID: 37522644
[TBL] [Abstract][Full Text] [Related]
10. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
[TBL] [Abstract][Full Text] [Related]
11. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
[TBL] [Abstract][Full Text] [Related]
12. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
[TBL] [Abstract][Full Text] [Related]
13. [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].
Wallbach M; Koziolek MJ; Wachter R
Internist (Berl); 2018 Oct; 59(10):1011-1020. PubMed ID: 30182192
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
Mann JA; Abraham WT
Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
[TBL] [Abstract][Full Text] [Related]
15. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.
Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389
[TBL] [Abstract][Full Text] [Related]
16. Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis.
Shi R; Sun T; Wang M; Xiang Q; Ding Y; Yin S; Chen Y; Shen L; Yu P; Chen X
Heliyon; 2024 Jan; 10(2):e24177. PubMed ID: 38293445
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of baroreflex activation therapy for heart failure: A meta-analysis of randomized controlled trials.
Cai G; Guo K; Zhang D; Qin S
Medicine (Baltimore); 2020 Nov; 99(45):e22951. PubMed ID: 33157936
[TBL] [Abstract][Full Text] [Related]
18. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
[TBL] [Abstract][Full Text] [Related]
19. Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure.
Lindenfeld J; Gupta R; Grazette L; Ruddy JM; Tsao L; Galle E; Rogers T; Sears S; Zannad F
JACC Heart Fail; 2021 Jun; 9(6):430-438. PubMed ID: 33992562
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure.
Gronda E; Brambilla G; Seravalle G; Maloberti A; Cairo M; Costantino G; Lovett E; Vanoli E; Mancia G; Grassi G
Clin Res Cardiol; 2016 Oct; 105(10):838-46. PubMed ID: 27120329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]